Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535264-25-000049
Filing Date
2025-08-14
Accepted
2025-08-14 14:58:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6477
  Complete submission text file 0001535264-25-000049.txt   8470
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Subject) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88813 | Film No.: 251217825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

EIN.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G